» Authors » Sonal S Noticewala

Sonal S Noticewala

Explore the profile of Sonal S Noticewala including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 155
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Morris V, Xiao W, Lin K, Wong C, Wotman M, Holliday E, et al.
Clin Cancer Res . 2025 Jan; PMID: 39873618
Background: While detection of circulating tumor DNA (ctDNA) weeks after surgery is linked to recurrence for other solid tumors, the optimal time point for ctDNA assessment as a prognostic biomarker...
2.
Fang P, Noticewala S, Wu S, Gunther J, Ludmir E, Medeiros L, et al.
Adv Radiat Oncol . 2024 Nov; 9(12):101650. PMID: 39553398
Purpose: Extranodal NK/T-cell lymphoma (ENKTCL) is rare in the Western Hemisphere and is commonly treated with combined modality therapy (CMT). Methods And Materials: We retrospectively reviewed 35 patients treated with...
3.
Corrigan K, Andring L, Das P, Pfennig C, Porter K, Ludmir E, et al.
Tech Innov Patient Support Radiat Oncol . 2024 Oct; 32:100271. PMID: 39403310
We hypothesized that pre-consult patient education videos can improve patient understanding about their diagnosis, lead to high satisfaction and low distress. In this pilot study, we developed a patient education...
4.
De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer A, et al.
medRxiv . 2024 Sep; PMID: 39314943
Background: Although escalated doses of radiation therapy (RT) for intrahepatic cholangiocarcinoma (iCCA) are associated with durable local control (LC) and prolonged survival, uncertainties persist regarding personalized RT based on biological...
5.
Lin T, McCaw Z, Koong A, Lin C, Abi Jaoude J, Patel R, et al.
Clin Cancer Res . 2024 Aug; 30(20):4791-4799. PMID: 39133081
Purpose: Survival analyses of novel agents with long-term responders often exhibit differential hazard rates over time. Such proportional hazards violations (PHV) may reduce the power of the log-rank test and...
6.
Ludmir E, Sherry A, Fellman B, Liu S, Bathala T, Haymaker C, et al.
J Clin Oncol . 2024 Aug; 42(32):3795-3805. PMID: 39102622
Purpose: The EXTEND trial tested the hypothesis that adding comprehensive metastasis-directed therapy (MDT) to chemotherapy would improve progression-free survival (PFS) over chemotherapy alone among patients with oligometastatic pancreatic ductal adenocarcinoma...
7.
Noticewala S, Das P
Cancer J . 2024 Jul; 30(4):227-231. PMID: 39042772
In locally advanced rectal cancer, neoadjuvant treatment has evolved from no preoperative treatment to the addition of radiation and systemic therapy and ultimately total neoadjuvant therapy. Total neoadjuvant therapy is...
8.
Shi C, De B, Tran Cao H, Liu S, Florez M, Kouzy R, et al.
Cancer Med . 2024 Jun; 13(12):e7434. PMID: 38923407
Introduction: With locally advanced pancreatic cancer (LAPC), uncontrolled local tumor growth frequently leads to mortality. Advancements in radiotherapy (RT) techniques have enabled conformal delivery of escalated-dose RT (EDR), which may...
9.
Chang E, Wong F, Chasen B, Erwin W, Das P, Holliday E, et al.
JNCI Cancer Spectr . 2024 May; 8(3). PMID: 38730548
Background: Traditional constraints specify that 700 cc of liver should be spared a hepatotoxic dose when delivering liver-directed radiotherapy to reduce the risk of inducing liver failure. We investigated the...
10.
Rooney M, Pasli M, Chang G, Das P, Koay E, Koong A, et al.
Cancers (Basel) . 2024 Jan; 16(1). PMID: 38201580
Background: Despite the increasing utilization of sphincter and/or organ-preservation treatment strategies, many patients with low-lying rectal cancers require abdominoperineal resection (APR), leading to permanent ostomy. Here, we aimed to characterize...